Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

February 01, 1997; Volume 51,Issue 2

Accelerated Communications

  • You have access
    Novel Subtype-Selective Nonpeptide Bradykinin Receptor Antagonists FR167344 and FR173657
    Ichiro Aramori, Junko Zenkoh, Noriyuki Morikawa, Nuala O’Donnell, Masayuki Asano, Kozo Nakamura, Morita Iwami, Hitoshi Kojo and Yoshitada Notsu
    Molecular Pharmacology February 1997, 51 (2) 171-176; DOI: https://doi.org/10.1124/mol.51.2.171
  • You have access
    Internal Trafficking and Surface Mobility of a Functionally Intact β2-Adrenergic Receptor-Green Fluorescent Protein Conjugate
    Larry S. Barak, Stephen S. G. Ferguson, Jie Zhang, Christopher Martenson, Tobias Meyer and Marc G. Caron
    Molecular Pharmacology February 1997, 51 (2) 177-184; DOI: https://doi.org/10.1124/mol.51.2.177

Articles

  • You have access
    Roles of Cholecystokinin Receptor Phosphorylation in Agonist-Stimulated Desensitization of Pancreatic Acinar Cells and Receptor-Bearing Chinese Hamster Ovary Cholecystokinin Receptor Cells
    Rammohan V. Rao, Belinda F. Roettger, Elizabeth M. Hadac and Laurence J. Miller
    Molecular Pharmacology February 1997, 51 (2) 185-192; DOI: https://doi.org/10.1124/mol.51.2.185
  • You have access
    Genistein-Induced Apoptosis of Prostate Cancer Cells is Preceded by a Specific Decrease in Focal Adhesion Kinase Activity
    Edward Kyle, Len Neckers, Chris Takimoto, Gregory Curt and Raymond Bergan
    Molecular Pharmacology February 1997, 51 (2) 193-200; DOI: https://doi.org/10.1124/mol.51.2.193
  • You have access
    β-Adrenoceptor Activation-Induced Placental Prorenin Secretion Is Mediated by Increased Renin Messenger RNA and Protein Synthesis
    Gregory J. Downing, Bingfang Yan and Alan M. Poisner
    Molecular Pharmacology February 1997, 51 (2) 201-208; DOI: https://doi.org/10.1124/mol.51.2.201
  • You have access
    Antisense Oligonucleotides Targeting Human Protein Kinase C-α Inhibit Phorbol Ester-Induced Reduction of Bradykinin-Evoked Calcium Mobilization in A549 Cells
    Luc Levesque, Nicholas M. Dean, Henri Sasmor and Stanley T. Crooke
    Molecular Pharmacology February 1997, 51 (2) 209-216; DOI: https://doi.org/10.1124/mol.51.2.209
  • You have access
    A New Linear V1A Vasopressin Antagonist and Its Use in Characterizing Receptor/G Protein Interactions
    Zuzana Strakova, Amalendra Kumar, A. John Watson and Melvyn S. Soloff
    Molecular Pharmacology February 1997, 51 (2) 217-224; DOI: https://doi.org/10.1124/mol.51.2.217
  • You have access
    Enhancement of Radiation-Inducible Hepatic Glutathione-S-Transferases Ya,Yb1, Yb2, Yc1, andYc2 Gene Expression by Oltipraz: Possible Role in Radioprotection
    Sang Geon Kim, Seon Young Nam, Choon Won Kim, Jeong Hee Kim, Chul Koo Cho and Seong Yul Yoo
    Molecular Pharmacology February 1997, 51 (2) 225-233; DOI: https://doi.org/10.1124/mol.51.2.225
  • You have access
    The Role of the Aspartate-Arginine-Tyrosine Triad in the m1 Muscarinic Receptor: Mutations of Aspartate 122 and Tyrosine 124 Decrease Receptor Expression but Do Not Abolish Signaling
    Zhi-Liang Lu, Carol A. Curtis, Philip G. Jones, Jose Pavia and Edward C. Hulme
    Molecular Pharmacology February 1997, 51 (2) 234-241; DOI: https://doi.org/10.1124/mol.51.2.234
  • You have access
    Selective Activation of Rolipram-Sensitive, cAMP-Specific Phosphodiesterase Isoforms by Phosphatidic Acid
    Georges Némoz, Claudio Sette and Marco Conti
    Molecular Pharmacology February 1997, 51 (2) 242-249; DOI: https://doi.org/10.1124/mol.51.2.242
  • You have access
    Structural and Functional Characterization of the Human α3 Nicotinic Subunit Gene Promoter
    Diego Fornasari, Elena Battaglioli, Adriano Flora, Susanna Terzano and Francesco Clementi
    Molecular Pharmacology February 1997, 51 (2) 250-261; DOI: https://doi.org/10.1124/mol.51.2.250
  • You have access
    1,5-Benzothiazepine Binding Domain Is Located on the Extracellular Side of the Cardiac L-Type Ca2+ Channel
    Junko Kurokawa, Satomi Adachi-Akahane and Taku Nagao
    Molecular Pharmacology February 1997, 51 (2) 262-268; DOI: https://doi.org/10.1124/mol.51.2.262
  • You have access
    Correlation between the Formation of Cleavable Complex with Topoisomerase I and Growth-Inhibitory Activity for Saintopin-Type Antibiotics
    Noboru Fujii, Yoshinori Yamashita, Tamio Mizukami and Hirofumi Nakano
    Molecular Pharmacology February 1997, 51 (2) 269-276; DOI: https://doi.org/10.1124/mol.51.2.269
  • You have access
    Diinosine Polyphosphates, a Group of Dinucleotides with Antagonistic Effects on Diadenosine Polyphosphate Receptor
    Jesús Pintor, Javier Gualix and M. Teresa Miras-Portugal
    Molecular Pharmacology February 1997, 51 (2) 277-284; DOI: https://doi.org/10.1124/mol.51.2.277
  • You have access
    Cell-Specific, Promoter-Dependent Mineralocorticoid Agonist Activity of Spironolactone
    Charbel Massaad, Marc Lombès, Martine Aggerbeck, Marie-Edith Rafestin-Oblin and Robert Barouki
    Molecular Pharmacology February 1997, 51 (2) 285-292; DOI: https://doi.org/10.1124/mol.51.2.285
  • You have access
    Molecular Cloning and Pharmacological Characterization of a Molluscan Octopamine Receptor
    Cindy C. Gerhardt, Remko A. Bakker, Gerard J. Piek, Rudi J. Planta, Erno Vreugdenhil, Josée E. Leysen and Harm Van Heerikhuizen
    Molecular Pharmacology February 1997, 51 (2) 293-300; DOI: https://doi.org/10.1124/mol.51.2.293
  • You have access
    Dual Agonistic and Antagonistic Property of Nonpeptide Angiotensin AT1 Ligands: Susceptibility to Receptor Mutations
    Signe Perlman, Claudio M. Costa-Neto, Ayumi A. Miyakawa, Hans T. Schambye, Siv A. Hjorth, Antonio C. M. Paiva, Ralph A. Rivero, William J. Greenlee and Thue W. Schwartz
    Molecular Pharmacology February 1997, 51 (2) 301-311; DOI: https://doi.org/10.1124/mol.51.2.301
  • You have access
    Pharmacology of Muscarinic Receptor Subtypes Constitutively Activated by G Proteins
    E. S. Burstein, T. A. Spalding and M. R. Brann
    Molecular Pharmacology February 1997, 51 (2) 312-319; DOI: https://doi.org/10.1124/mol.51.2.312
  • You have access
    “Orphan” α6 Nicotinic AChR Subunit Can Form a Functional Heteromeric Acetylcholine Receptor
    V. Gerzanich, A. Kuryatov, R. Anand and J. Lindstrom
    Molecular Pharmacology February 1997, 51 (2) 320-327; DOI: https://doi.org/10.1124/mol.51.2.320
  • You have access
    Contrasting Actions of Lanthanum on Different Recombinant γ-Aminobutyric Acid Receptor Isoforms Expressed in L929 Fibroblasts
    Nina C. Saxena, Torben R. Neelands and Robert L. Macdonald
    Molecular Pharmacology February 1997, 51 (2) 328-335; DOI: https://doi.org/10.1124/mol.51.2.328
  • You have access
    Determinants of Specificity for α-Conotoxin MII on α3β2 Neuronal Nicotinic Receptors
    Scott C. Harvey, J. Michael Mcintosh, G. Edward Cartier, Floyd N. Maddox and Charles W. Luetje
    Molecular Pharmacology February 1997, 51 (2) 336-342; DOI: https://doi.org/10.1124/mol.51.2.336
  • You have access
    The Long Cytoplasmic Carboxyl Terminus of the Prostaglandin E2 Receptor EP4 Subtype Is Essential for Agonist-Induced Desensitization
    Murat Bastepe and Barrie Ashby
    Molecular Pharmacology February 1997, 51 (2) 343-349; DOI: https://doi.org/10.1124/mol.51.2.343
  • You have access
    Binding of a Thrombin Receptor Tethered Ligand Analogue to Human Platelet Thrombin Receptor
    Ho-Sam Ahn, Carolyn Foster, George Boykow, Leyla Arik, April Smith-Torhan, David Hesk and Meeta Chatterjee
    Molecular Pharmacology February 1997, 51 (2) 350-356; DOI: https://doi.org/10.1124/mol.51.2.350
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 51 (2)
Molecular Pharmacology
Vol. 51, Issue 2
1 Feb 1997
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Accelerated Communications
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics